Patient presents for routine lipid panel screening or follow-up evaluation of dyslipidemia, hyperlipidemia, hypercholesterolemia, or high cholesterol.  Relevant family history of coronary artery disease, cerebrovascular accident, or peripheral artery disease was reviewed.  Patient reports adherence to or non-adherence with current lipid-lowering therapy, including statins, fibrates, bile acid sequestrants, niacin, or PCSK9 inhibitors.  Dietary habits, exercise regimen, and smoking status were discussed.  Physical examination findings are unremarkable or may include findings suggestive of hyperlipidemia such as xanthomas or xanthelasmas.  Laboratory results for total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, non-HDL cholesterol, and cholesterolLDL ratio are reviewed and documented.  Assessment includes a diagnosis of hypercholesterolemia, mixed hyperlipidemia, hypertriglyceridemia, isolated low HDL cholesterol, or normal lipid panel.  Plan includes lifestyle modifications such as diet and exercise, continuation or adjustment of current lipid-lowering medications, initiation of new pharmacotherapy, or referral to a cardiologist or lipid specialist for further evaluation and management.  Patient education provided on the importance of cholesterol management, risk factors for cardiovascular disease, and medication adherence.  Follow-up lipid panel scheduled to monitor treatment efficacy and disease progression.  ICD-10 codes such as E78.0, E78.1, E78.2, E78.5, or E78.9 may be applicable.  CPT codes for lipid panel testing, such as 80061, may be billed.